Table 1 Indicators used to assess the quality of antibiotic prescribing
From: Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
Indicator’s description | Indicator’s acronym or shortened name |
|---|---|
Consumption of antibacterials for systemic use (J01) expressed in defined daily doses per 1000 inhabitants per day (DIDs) | Total consumption J01 |
Consumption of beta-lactamase sensitive penicillins (J01 CE) expressed as percentage of the total consumption of antibacterials for systemic use (J01); i.e. relative consumption of beta-lactamase sensitive penicillins | J01 CE% |
Consumption of combination of penicillins, including beta-lactamase inhibitor (J01CR) expressed as percentage of the total consumption of antibacterials for systemic use (J01); i.e. relative consumption of combination of penicillins, including beta-lactamase inhibitor | J01CR% |
Consumption of third- and fourth-generation cephalosporins (J01(DD + DE)) expressed as percentage of the total consumption of antibacterials for systemic use (J01); i.e. relative consumption of third- and fourth-generation cephalosporins | J01DD + DE% |
Consumption of fluoroquinolones (J01MA) expressed as percentage of the total consumption of antibacterials for systemic use (J01); i.e. relative consumption of fluoroquinolones | J01MA% |
Ratio of the consumption of broad-spectrum (J01(CR + DC + DD+(F-FA01))) to the consumption of narrow-spectrum penicillins, cephalosporins and macrolides (J01(CE + DB + FA01)) | J01B/N% |